Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001062993-24-015670
Filing Date
2024-08-26
Accepted
2024-08-26 17:40:16
Documents
2
Period of Report
2024-08-20

Document Format Files

Seq Description Document Type Size
1 AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4a.html 4/A  
1 AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4a.xml 4/A 4017
2 POA exhibit24.txt EX-24 1852
  Complete submission text file 0001062993-24-015670.txt   7497
Mailing Address 16305 36TH AVENUE N SUITE 100 MINNEAPOLIS MN 55446
Business Address 16305 36TH AVENUE N SUITE 100 MINNEAPOLIS MN 55446 763-392-0767
Celcuity Inc. (Issuer) CIK: 0001603454 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)

Mailing Address C/O CELCUITY, 16305 36TH AVENUE N. #450 MINNEAPOLIS MN 55446
Business Address
Hahne Vicky (Reporting) CIK: 0001716043 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-38207 | Film No.: 241242610